Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes

作者: Satoshi Watanabe , Katsuya Deguchi , Rongxiu Zheng , Hidemasa Tamai , Li-xin Wang

DOI: 10.4049/JIMMUNOL.181.5.3291

关键词: T cellImmune systemCytotoxic T cellIL-2 receptorImmunologyBiologyCD8Antigen-presenting cellCancer researchTumor progressionInterleukin 21

摘要: … In vitro studies provided evidence that MDSC can do the following: 1) inhibit T cell proliferation in response to various … The mechanisms of suppression by MDSC on tumor-specific T …

参考文章(49)
Rongxiu Zheng, Jorgen Kjaergaard, Walter T. Lee, Peter A. Cohen, Suyu Shu, Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy. Cancer treatment and research. ,vol. 135, pp. 223- 237 ,(2007) , 10.1007/978-0-387-69219-7_17
Stephanie K. Bunt, Pratima Sinha, Virginia K. Clements, Jeff Leips, Suzanne Ostrand-Rosenberg, Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression Journal of Immunology. ,vol. 176, pp. 284- 290 ,(2006) , 10.4049/JIMMUNOL.176.1.284
Steven A. Rosenberg, Suyu Shu, Adoptive Immunotherapy of Newly Induced Murine Sarcomas Cancer Research. ,vol. 45, pp. 1657- 1662 ,(1985)
Yuanqing Liu, Jo A. Van Ginderachter, Lea Brys, Patrick De Baetselier, Geert Raes, Anja B. Geldhof, Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells Journal of Immunology. ,vol. 170, pp. 5064- 5074 ,(2003) , 10.4049/JIMMUNOL.170.10.5064
Sergei Kusmartsev, Yulia Nefedova, Daniel Yoder, Dmitry I. Gabrilovich, Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology. ,vol. 172, pp. 989- 999 ,(2004) , 10.4049/JIMMUNOL.172.2.989
Vincenzo Bronte, Elisa Apolloni, Anna Cabrelle, Roberto Ronca, Paolo Serafini, Paola Zamboni, Nicholas P. Restifo, Paola Zanovello, Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood. ,vol. 96, pp. 3838- 3846 ,(2000) , 10.1182/BLOOD.V96.12.3838
Suyu Shu, Hirohisa Yoshizawa, Alfred E. Chang, Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. Journal of Immunology. ,vol. 147, pp. 729- 737 ,(1991)
Suyu Shu, T. Chou, S. A. Rosenberg, Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. Journal of Immunology. ,vol. 139, pp. 295- 304 ,(1987)
Scott Maffett, Gene H. Barnett, Glen H. J. Stevens, Peter A. Cohen, Gregory E. Plautz, Julian Kim, Suyu Shu, David W. Miller, T cell adoptive immunotherapy of newly diagnosed gliomas. Clinical Cancer Research. ,vol. 6, pp. 2209- 2218 ,(2000)